ANEB (Anebulo Pharma) יחס שווי שוק לשווי בספרים

This chart of Anebulo Pharmaceuticals (ANEB) value on GURU.Markets, which currently stands at 1.89, reflects the dynamics of a company utilizing AI to develop cannabinoid antidotes via automated tablet production. The business faces risks regarding international patent protection and logistical challenges in raw material procurement. The current development vector relies on R&D in acute intoxication therapy amid the global legalization of marijuana.

The selection of promising issuers is based on comparing the market value of assets with their actual book value. This ratio measures the price premium over net assets, revealing the degree to which a security is overvalued relative to the fundamental median. For Anebulo Pharmaceuticals (ANEB), this calculation is critical due to the narrow niche of cannabinoid antidotes and the risk of expansion by major pharma behemoths. Analyzing the current market value to book value ratio allows for the avoidance of purchasing the asset at a historical peak.